Chemoinformaics analysis of Isorhamnetin 3-O-robinobioside
| Molecular Weight | 624.548 | nRot | 7 |
| Heavy Atom Molecular Weight | 592.292 | nRig | 30 |
| Exact Molecular Weight | 624.169 | nRing | 5 |
| Solubility: LogS | -4.032 | nHRing | 3 |
| Solubility: LogP | -0.535 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 76 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 2 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 16 | No. of Arom Bond | 17 |
| nHA | 16 | APOL | 80.9294 |
| nHD | 9 | BPOL | 43.3866 |
| QED | 0.147 |
| Synth | 4.749 |
| Natural Product Likeliness | 1.934 |
| NR-PPAR-gamma | 0.952 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.991 |
| HIA | 0.927 |
| CACO-2 | -6.298 |
| MDCK | 0.0000418 |
| BBB | 0.154 |
| PPB | 0.792273 |
| VDSS | 0.696 |
| FU | 0.234723 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.06 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.388 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.18 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.006 |
| CL | 1.375 |
| T12 | 0.43 |
| hERG | 0.019 |
| Ames | 0.82 |
| ROA | 0.036 |
| SkinSen | 0.018 |
| Carcinogencity | 0.065 |
| EI | 0.007 |
| Respiratory | 0.018 |
| NR-Aromatase | 0.908 |
| Antiviral | Yes |
| Prediction | 0.807364 |